Coherus BioSciences Ownership 2024 | Who Owns Coherus BioSciences Now?
Institutional Ownership
86.67%
Insider Ownership
1.39%
Retail Ownership
11.94%
Institutional Holders
142.00
Coherus BioSciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 11.93% | 0.00% | 11,230,522 | -844,173 | -6.99% | 26,840,947 | Mar 31, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 11.04% | 0.73% | 10,400,000 | 10,004,793 | 2531.53% | 24,856,000 | Mar 31, 2024 |
| VANGUARD GROUP INC | 10.70% | 0.00% | 10,079,554 | -277,858 | -2.68% | 24,090,134 | Mar 31, 2024 |
| TEMASEK HOLDINGS (PRIVATE) LTD | 7.84% | 0.10% | 7,381,116 | - | - | 17,640,867 | Mar 31, 2024 |
| KOHLBERG KRAVIS ROBERTS & CO. L.P. | 3.22% | 0.19% | 3,036,076 | - | - | 7,256,224 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 2.91% | 0.00% | 2,742,627 | 754,730 | 37.97% | 6,554,879 | Mar 31, 2024 |
| MORGAN STANLEY | 2.83% | 0.00% | 2,664,169 | 594,316 | 28.71% | 6,367,366 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 2.58% | 0.00% | 2,427,225 | 308,421 | 14.56% | 5,801,067,000 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.34% | 0.00% | 2,203,694 | 122,093 | 5.87% | 5,267,385 | Mar 31, 2024 |
| BARCLAYS PLC | 2.19% | 0.00% | 2,065,351 | -1,419,044 | -40.73% | 4,937,000 | Mar 31, 2024 |
| STATE STREET CORP | 2.12% | 0.00% | 1,995,738 | -68,588 | -3.32% | 4,769,814 | Mar 31, 2024 |
| C WORLDWIDE GROUP HOLDING A/S | 2.05% | 0.05% | 1,928,464 | - | - | 4,609,000 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 1.82% | 0.00% | 1,714,574 | 876,999 | 104.71% | 4,097,832 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.55% | 0.01% | 1,462,013 | 11,661 | 0.80% | 3,494,211 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.34% | 0.00% | 1,257,363 | -1,584,956 | -55.76% | 3,005,098 | Mar 31, 2024 |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1.33% | 0.05% | 1,255,937 | 89,210 | 7.65% | 3,001,689 | Mar 31, 2024 |
| TEJARA CAPITAL LTD | 1.12% | 0.93% | 1,055,386 | 1,055,386 | 100.00% | 2,522,373 | Mar 31, 2024 |
| PEREGRINE CAPITAL MANAGEMENT LLC | 1.08% | 0.07% | 1,016,455 | -73,506 | -6.74% | 2,429,327 | Mar 31, 2024 |
| CM MANAGEMENT, LLC | 1.06% | 2.01% | 1,000,000 | 176,000 | 21.36% | 2,390,000 | Mar 31, 2024 |
| ALPHACENTRIC ADVISORS LLC | 1.06% | 1.44% | 1,000,000 | - | - | 2,390,000 | Mar 31, 2024 |
Coherus BioSciences's largest institutional shareholder is BLACKROCK INC., holding 11.93% of the company's total share outstanding, currently valued at $26.84M. The top 10 institutional shareholders own together 57.59% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CM MANAGEMENT, LLC | 1.06% | 2.01% | 1,000,000 | 176,000 | 21.36% | 2,390,000 | Mar 31, 2024 |
| ALPHACENTRIC ADVISORS LLC | 1.06% | 1.44% | 1,000,000 | - | - | 2,390,000 | Mar 31, 2024 |
| TEJARA CAPITAL LTD | 1.12% | 0.93% | 1,055,386 | 1,055,386 | 100.00% | 2,522,373 | Mar 31, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 11.04% | 0.73% | 10,400,000 | 10,004,793 | 2531.53% | 24,856,000 | Mar 31, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.29% | 0.53% | 270,000 | 160,000 | 145.45% | 645,300 | Mar 31, 2024 |
| BRIDGE CITY CAPITAL, LLC | 0.33% | 0.27% | 315,384 | 2,450 | 0.78% | 753,768 | Mar 31, 2024 |
| KOHLBERG KRAVIS ROBERTS & CO. L.P. | 3.22% | 0.19% | 3,036,076 | - | - | 7,256,224 | Mar 31, 2024 |
| TYCHE WEALTH PARTNERS LLC | 0.23% | 0.13% | 215,902 | - | - | 516,006 | Mar 31, 2024 |
| PENNANT INVESTORS, LP | 0.18% | 0.10% | 168,100 | - | - | 401,759 | Mar 31, 2024 |
| TEMASEK HOLDINGS (PRIVATE) LTD | 7.84% | 0.10% | 7,381,116 | - | - | 17,640,867 | Mar 31, 2024 |
| CLEARLINE CAPITAL LP | 0.83% | 0.09% | 784,449 | 784,449 | 100.00% | 1,874,833 | Mar 31, 2024 |
| KNOTT DAVID M JR | 0.11% | 0.09% | 106,185 | -420,127 | -79.82% | 254,000 | Mar 31, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.04% | 0.09% | 41,879 | 41,879 | 100.00% | 100,091 | Mar 31, 2024 |
| PEREGRINE CAPITAL MANAGEMENT LLC | 1.08% | 0.07% | 1,016,455 | -73,506 | -6.74% | 2,429,327 | Mar 31, 2024 |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1.33% | 0.05% | 1,255,937 | 89,210 | 7.65% | 3,001,689 | Mar 31, 2024 |
| C WORLDWIDE GROUP HOLDING A/S | 2.05% | 0.05% | 1,928,464 | - | - | 4,609,000 | Mar 31, 2024 |
| ELCO MANAGEMENT CO., LLC | 0.02% | 0.03% | 20,480 | 5,286 | 34.79% | 48,948 | Mar 31, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | 0.10% | 0.03% | 98,229 | - | - | 234,767 | Mar 31, 2024 |
| CARR FINANCIAL GROUP CORP | 0.04% | 0.03% | 35,195 | - | - | 84,116 | Mar 31, 2024 |
| SARGENT INVESTMENT GROUP, LLC | 0.05% | 0.03% | 48,700 | 22,640 | 86.88% | 116,393 | Mar 31, 2024 |
The largest Coherus BioSciences shareholder by % of total assets is CM MANAGEMENT, LLC. The company owns 1.00M shares of Coherus BioSciences (CHRS), representing 2.01% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | 11.04% | 0.73% | 10,400,000 | 10,004,793 | 2531.53% | 24,856,000 | Mar 31, 2024 |
| TEJARA CAPITAL LTD | 1.12% | 0.93% | 1,055,386 | 1,055,386 | 100.00% | 2,522,373 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 1.82% | 0.00% | 1,714,574 | 876,999 | 104.71% | 4,097,832 | Mar 31, 2024 |
| CLEARLINE CAPITAL LP | 0.83% | 0.09% | 784,449 | 784,449 | 100.00% | 1,874,833 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 2.91% | 0.00% | 2,742,627 | 754,730 | 37.97% | 6,554,879 | Mar 31, 2024 |
| MORGAN STANLEY | 2.83% | 0.00% | 2,664,169 | 594,316 | 28.71% | 6,367,366 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.42% | 0.00% | 391,363 | 391,363 | 100.00% | 935,358 | Mar 31, 2024 |
| LAZARD ASSET MANAGEMENT LLC | 0.41% | 0.00% | 387,700 | 374,307 | 2794.80% | 926,000 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.36% | 0.00% | 341,202 | 341,202 | 100.00% | 815,473 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 2.58% | 0.00% | 2,427,225 | 308,421 | 14.56% | 5,801,067,000 | Mar 31, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.37% | 0.00% | 346,157 | 302,570 | 694.17% | 827,315 | Mar 31, 2024 |
| MACQUARIE GROUP LTD | 0.96% | 0.00% | 899,999 | 250,000 | 38.46% | 2,151,000 | Mar 31, 2024 |
| CM MANAGEMENT, LLC | 1.06% | 2.01% | 1,000,000 | 176,000 | 21.36% | 2,390,000 | Mar 31, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.29% | 0.53% | 270,000 | 160,000 | 145.45% | 645,300 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.16% | 0.00% | 152,328 | 152,328 | 100.00% | 364,000 | Mar 31, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.16% | 0.02% | 146,231 | 146,231 | 100.00% | 349,492 | Mar 31, 2024 |
| CITIGROUP INC | 0.55% | 0.00% | 516,716 | 142,909 | 38.23% | 1,234,951 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.34% | 0.00% | 2,203,694 | 122,093 | 5.87% | 5,267,385 | Mar 31, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.74% | 0.01% | 700,000 | 115,000 | 19.66% | 1,673,000 | Mar 31, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | 0.21% | 0.00% | 196,625 | 113,000 | 135.13% | 469,934 | Mar 31, 2024 |
As of Mar 31 2024, Coherus BioSciences's largest institutional buyer is RUBRIC CAPITAL MANAGEMENT LP. The company purchased 10.00M stocks of CHRS, valued at $24.86M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PICTET ASSET MANAGEMENT HOLDING SA | - | - | - | -2,481,848 | -100.00% | - | Mar 31, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -1,614,278 | -100.00% | - | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.34% | 0.00% | 1,257,363 | -1,584,956 | -55.76% | 3,005,098 | Mar 31, 2024 |
| BARCLAYS PLC | 2.19% | 0.00% | 2,065,351 | -1,419,044 | -40.73% | 4,937,000 | Mar 31, 2024 |
| DEUTSCHE BANK AG\ | 0.13% | 0.00% | 125,513 | -1,006,726 | -88.91% | 299,976 | Mar 31, 2024 |
| BLACKROCK INC. | 11.93% | 0.00% | 11,230,522 | -844,173 | -6.99% | 26,840,947 | Mar 31, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.10% | 0.00% | 95,056 | -666,263 | -87.51% | 227,184 | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -592,232 | -100.00% | - | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -583,671 | -100.00% | - | Mar 31, 2024 |
| KNOTT DAVID M JR | 0.11% | 0.09% | 106,185 | -420,127 | -79.82% | 254,000 | Mar 31, 2024 |
| AQR CAPITAL MANAGEMENT LLC | - | - | - | -371,366 | -100.00% | - | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -340,787 | -100.00% | - | Mar 31, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -313,134 | -100.00% | - | Mar 31, 2024 |
| SHAOLIN CAPITAL MANAGEMENT LLC | - | - | - | -308,200 | -100.00% | - | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.09% | 0.00% | 80,063 | -307,177 | -79.32% | 191,351 | Mar 31, 2024 |
| VANGUARD GROUP INC | 10.70% | 0.00% | 10,079,554 | -277,858 | -2.68% | 24,090,134 | Mar 31, 2024 |
| CREDIT SUISSE AG/ | 0.06% | 0.00% | 58,431 | -262,070 | -81.77% | 139,650 | Mar 31, 2024 |
| HRT FINANCIAL LP | - | - | - | -235,077 | -100.00% | - | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 0.24% | - | 227,079 | -208,587 | -47.88% | 542,719 | Mar 31, 2024 |
| SWISS NATIONAL BANK | - | - | - | -196,000 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Coherus BioSciences's biggest institutional seller is PICTET ASSET MANAGEMENT HOLDING SA. The company sold -2.48M shares of CHRS, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TEJARA CAPITAL LTD | 1.12% | 0.93% | 1,055,386 | 1,055,386 | 100.00% | 2,522,373 | Mar 31, 2024 |
| CLEARLINE CAPITAL LP | 0.83% | 0.09% | 784,449 | 784,449 | 100.00% | 1,874,833 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.42% | 0.00% | 391,363 | 391,363 | 100.00% | 935,358 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.16% | 0.00% | 152,328 | 152,328 | 100.00% | 364,000 | Mar 31, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.16% | 0.02% | 146,231 | 146,231 | 100.00% | 349,492 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.08% | - | 73,200 | 73,200 | 100.00% | 174,948 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.07% | - | 68,400 | 68,400 | 100.00% | 163,476 | Mar 31, 2024 |
| RFG ADVISORY, LLC | 0.06% | 0.00% | 59,210 | 59,210 | 100.00% | 141,512 | Mar 31, 2024 |
| BARCLAYS PLC | 0.05% | - | 49,900 | 49,900 | 100.00% | 119,000 | Mar 31, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.04% | 0.09% | 41,879 | 41,879 | 100.00% | 100,091 | Mar 31, 2024 |
| ATOM INVESTORS LP | 0.04% | 0.01% | 39,164 | 39,164 | 100.00% | 93,602 | Mar 31, 2024 |
| TORNO CAPITAL, LLC | 0.03% | 0.00% | 30,000 | 30,000 | 100.00% | 71,700 | Mar 31, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | 0.03% | 0.01% | 23,559 | 23,559 | 100.00% | 56,306 | Mar 31, 2024 |
| QUANTBOT TECHNOLOGIES LP | 0.02% | 0.00% | 19,900 | 19,900 | 100.00% | 47,561 | Mar 31, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.02% | 0.00% | 16,211 | 16,211 | 100.00% | 39,000 | Mar 31, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | 0.01% | 0.01% | 13,325 | 13,325 | 100.00% | 31,847 | Mar 31, 2024 |
| TORNO CAPITAL, LLC | 0.01% | 0.00% | 10,000 | 10,000 | 100.00% | 23,900 | Mar 31, 2024 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 0.01% | - | 7,350 | 7,350 | 100.00% | 17,567 | Mar 31, 2024 |
| 0.00% | 0.00% | 1,066 | 1,066 | 100.00% | 2,549 | Mar 31, 2024 | |
| MAIN STREET GROUP, LTD | 0.00% | 0.00% | 200 | 200 | 100.00% | 480 | Mar 31, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.00% | - | 123 | 123 | 100.00% | 295,000 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 31 | 31 | 100.00% | 74 | Mar 31, 2024 |
Coherus BioSciences's largest new institutional shareholder by number of shares is TEJARA CAPITAL LTD, purchased 1.06M shares, valued at $2.52M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PICTET ASSET MANAGEMENT HOLDING SA | - | - | - | -2,481,848 | -100.00% | - | Mar 31, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -1,614,278 | -100.00% | - | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -592,232 | -100.00% | - | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -583,671 | -100.00% | - | Mar 31, 2024 |
| AQR CAPITAL MANAGEMENT LLC | - | - | - | -371,366 | -100.00% | - | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -340,787 | -100.00% | - | Mar 31, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -313,134 | -100.00% | - | Mar 31, 2024 |
| SHAOLIN CAPITAL MANAGEMENT LLC | - | - | - | -308,200 | -100.00% | - | Mar 31, 2024 |
| HRT FINANCIAL LP | - | - | - | -235,077 | -100.00% | - | Mar 31, 2024 |
| SWISS NATIONAL BANK | - | - | - | -196,000 | -100.00% | - | Mar 31, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -147,646 | -100.00% | - | Mar 31, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | - | - | - | -135,804 | -100.00% | - | Mar 31, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -127,610 | -100.00% | - | Mar 31, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | - | - | - | -73,102 | -100.00% | - | Mar 31, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | - | - | - | -70,529 | -100.00% | - | Mar 31, 2024 |
| NOMURA HOLDINGS INC | - | - | - | -68,300 | -100.00% | - | Mar 31, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -62,451 | -100.00% | - | Mar 31, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -51,591 | -100.00% | - | Mar 31, 2024 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -45,854 | -100.00% | - | Mar 31, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -37,952 | -100.00% | - | Mar 31, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -33,267 | -100.00% | - | Mar 31, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | - | - | - | -27,802 | -100.00% | - | Mar 31, 2024 |
| JANUS HENDERSON GROUP PLC | - | - | - | -26,496 | -100.00% | - | Mar 31, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | - | - | - | -24,261 | -100.00% | - | Mar 31, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -23,950 | -100.00% | - | Mar 31, 2024 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | - | - | - | -22,718 | -100.00% | - | Mar 31, 2024 |
| RPO LLC | - | - | - | -19,587 | -100.00% | - | Mar 31, 2024 |
| CREATIVE PLANNING | - | - | - | -15,150 | -100.00% | - | Mar 31, 2024 |
| VONTOBEL HOLDING LTD. | - | - | - | -15,000 | -100.00% | - | Mar 31, 2024 |
| BAADER BANK AKTIENGESELLSCHAFT | - | - | - | -14,020 | -100.00% | - | Mar 31, 2024 |
| AMERIPRISE FINANCIAL INC | - | - | - | -13,666 | -100.00% | - | Mar 31, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -13,003 | -100.00% | - | Mar 31, 2024 |
| TRINITYPOINT WEALTH, LLC | - | - | - | -12,038 | -100.00% | - | Mar 31, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | - | - | - | -11,892 | -100.00% | - | Mar 31, 2024 |
| GREAT WEST LIFE ASSURANCE CO /CAN/ | - | - | - | -11,699 | -100.00% | - | Mar 31, 2024 |
| ADVISORY SERVICES NETWORK, LLC | - | - | - | -9,150 | -100.00% | - | Mar 31, 2024 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | - | - | - | -4,000 | -100.00% | - | Mar 31, 2024 |
| WOLVERINE ASSET MANAGEMENT LLC | - | - | - | -2,573 | -100.00% | - | Mar 31, 2024 |
| POINT72 EUROPE (LONDON) LLP | - | - | - | -1,980 | -100.00% | - | Mar 31, 2024 |
| QUADRANT CAPITAL GROUP LLC | - | - | - | -457 | -100.00% | - | Mar 31, 2024 |
| SECURITY NATIONAL BANK | - | - | - | -52 | -100.00% | - | Mar 31, 2024 |
Coherus BioSciences's largest sold out institutional shareholder by shares sold is PICTET ASSET MANAGEMENT HOLDING SA, sold -2.48M shares, valued at -, as of undefined.
Coherus BioSciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| SCHRODER GLOBAL SERIES TRUST | 11.73% | 23,934 | - | - | Jan 31, 2021 |
| Vanguard Montgomery Funds | 6.90% | 277,976 | - | - | Dec 31, 2023 |
| HIGHLAND FUNDS II | 2.50% | 37,000 | - | - | Dec 31, 2023 |
| BANCROFT FUND LTD | 1.08% | 1,500,000 | -1,500,000 | -50.00% | Dec 29, 2023 |
| Delaware Enhanced Global Dividend & Income Fund | 1.07% | 394,000 | - | - | Feb 28, 2023 |
| ELLSWORTH GROWTH & INCOME FUND LTD | 1.07% | 1,500,000 | -1,500,000 | -50.00% | Dec 29, 2023 |
| Manager Directed Portfolios | 1.06% | 173,334 | - | - | Jan 31, 2024 |
| GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC | 0.95% | 750,000 | -750,000 | -50.00% | Dec 29, 2023 |
| AB DISCOVERY GROWTH FUND, INC. | 0.87% | 1,296,872 | - | - | Jan 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.74% | 790,000 | - | - | Dec 29, 2023 |
| DELAWARE INVESTMENTS DIVIDEND & INCOME FUND, INC | 0.62% | 163,000 | - | - | Feb 28, 2023 |
| NUVEEN INVESTMENT TRUST | 0.62% | 245,199 | - | - | Dec 31, 2023 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.61% | 650,000 | 151,400 | 30.37% | Dec 29, 2023 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.60% | 111,923 | - | - | Dec 29, 2023 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.59% | 543,726 | - | - | Jan 31, 2024 |
| GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC | 0.56% | 445,000 | - | - | Dec 29, 2023 |
| ELLSWORTH GROWTH & INCOME FUND LTD | 0.52% | 735,000 | - | - | Dec 29, 2023 |
| BANCROFT FUND LTD | 0.48% | 665,000 | - | - | Dec 29, 2023 |
| UBS RELATIONSHIP FUNDS | 0.41% | 98,000 | - | - | Jun 30, 2020 |
| TETON WESTWOOD FUNDS | 0.39% | 255,000 | - | - | Dec 29, 2023 |
| SYNTAX ETF TRUST | 0.27% | 8,833 | - | - | Dec 31, 2023 |
| ROYCE CAPITAL FUND | 0.21% | 79,312 | - | - | Dec 31, 2023 |
| 360 Funds | 0.17% | 7,214 | 1,783 | 32.83% | Feb 29, 2024 |
| ALGER FUNDS | 0.16% | 155,763 | - | - | Jan 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.16% | 167,000 | - | - | Dec 29, 2023 |
| TETON WESTWOOD FUNDS | 0.15% | 100,000 | -250,000 | -71.43% | Dec 29, 2023 |
| VANGUARD HORIZON FUNDS | 0.14% | 2,975,916 | 998,975 | 50.53% | Dec 31, 2023 |
| VANGUARD EXPLORER FUND | 0.14% | 1,693,303 | - | - | Jan 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.13% | 76,742 | - | - | Dec 31, 2023 |
| VANGUARD VALLEY FORGE FUNDS | 0.13% | 65,031 | - | - | Dec 31, 2023 |
| DSS AMERICAFIRST QUANTITATIVE FUNDS | 0.12% | 2,793 | - | - | Dec 29, 2023 |
| TEKLA HEALTHCARE INVESTORS | 0.11% | 126,361 | - | - | Dec 31, 2023 |
| VANGUARD ADMIRAL FUNDS | 0.09% | 409,073 | - | - | Feb 29, 2024 |
| World Funds Trust | 0.09% | 52,658 | - | - | Jan 31, 2024 |
| ROYCE VALUE TRUST, INC. | 0.09% | 106,700 | - | - | Dec 31, 2023 |
| Voya EQUITY TRUST | 0.08% | 121,437 | - | - | Feb 29, 2024 |
| BNY MELLON INDEX FUNDS, INC. | 0.08% | 89,063 | - | - | Jan 31, 2024 |
| Delaware Enhanced Global Dividend & Income Fund | 0.08% | 29,000 | - | - | Feb 28, 2023 |
| AMG FUNDS III | 0.07% | 11,344 | - | - | Feb 29, 2024 |
| BNY MELLON INVESTMENT PORTFOLIOS | 0.06% | 37,785 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.05% | 27,061 | -2,203 | -7.53% | Apr 30, 2021 |
| DELAWARE GROUP EQUITY FUNDS V | 0.05% | 2,828,000 | - | - | Feb 29, 2024 |
| Humankind Benefit Corp | 0.04% | 937 | - | - | Dec 31, 2023 |
| BNY Mellon Strategic Funds, Inc. | 0.04% | 94,665 | - | - | Mar 31, 2024 |
| DELAWARE INVESTMENTS DIVIDEND & INCOME FUND, INC | 0.04% | 10,000 | - | - | Feb 28, 2023 |
| DELAWARE VIP TRUST | 0.03% | 115,000 | - | - | Dec 29, 2023 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 14,337 | - | - | Dec 31, 2023 |
| OBERWEIS FUNDS | 0.03% | 22,300 | - | - | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 179,604 | 10,364 | 6.12% | Dec 31, 2023 |
| STATE STREET INSTITUTIONAL FUNDS | 0.02% | 20,875 | - | - | Dec 31, 2023 |
| PFM Multi-Manager Series Trust | 0.02% | 17,260 | - | - | Dec 31, 2023 |
| IndexIQ ETF Trust | 0.02% | 46,697 | -4,191 | -8.24% | Jan 31, 2024 |
| PAX WORLD FUNDS SERIES TRUST I | 0.02% | 365,248 | - | - | Dec 31, 2023 |
| FIDELITY MT VERNON STREET TRUST | 0.02% | 469,916 | - | - | Feb 29, 2024 |
| AMG Funds I | 0.02% | 23,101 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.02% | 36,075 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.01% | 6,037,032 | 1,595,263 | 35.92% | Dec 31, 2023 |
| Vericimetry Funds | 0.01% | 1,330 | - | - | Dec 31, 2023 |
| Bernstein Fund Inc | 0.01% | 122,049 | - | - | Dec 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.01% | 41,837 | - | - | Jan 31, 2024 |
| FRONTIER FUNDS, INC. | 0.01% | 4,125 | - | - | Dec 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,173 | - | - | Dec 31, 2023 |
| Fidelity Commonwealth Trust II | 0.01% | 61,882 | - | - | Aug 31, 2023 |
| Nushares ETF Trust | 0.01% | 57,274 | - | - | Jan 31, 2024 |
| NEXPOINT FUNDS I | 0.01% | 30,000 | - | - | Dec 31, 2023 |
| FIDELITY SECURITIES FUND | 0.01% | 715,928 | - | - | Jan 31, 2024 |
| Brown Advisory Funds | 0.01% | 292,762 | - | - | Dec 31, 2023 |
| JNL VARIABLE FUND LLC | 0.01% | 40,328 | - | - | Mar 31, 2020 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 22,605 | - | - | Feb 29, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.01% | 29,773 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.01% | 24,484 | 19,263 | 368.95% | Dec 31, 2023 |
| ALPS ETF Trust | 0.01% | 74,812 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.01% | 78,069 | 31,996 | 69.45% | Dec 31, 2023 |
| AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS) | 0.01% | 194,716 | - | - | Jan 31, 2024 |
| EXCHANGE TRADED CONCEPTS TRUST | 0.01% | 31,299 | - | - | Feb 29, 2024 |
| BlackRock ETF Trust | 0.01% | 4,842 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.01% | 14,910 | -1,104 | -6.89% | Dec 31, 2023 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.01% | 279,908 | -32,011 | -10.26% | Dec 31, 2023 |
| LORD ABBETT SECURITIES TRUST | 0.00% | 22,659 | - | - | Jan 31, 2024 |
| ETF Managers Trust | 0.00% | 36,690 | - | - | Dec 31, 2023 |
| ROYCE FUND | 0.00% | 28,887 | - | - | Dec 31, 2023 |
| Direxion Shares ETF Trust | 0.00% | 688,137 | - | - | Jan 31, 2024 |
| HUSSMAN INVESTMENT TRUST | 0.00% | 15,600 | - | - | Dec 31, 2023 |
| SSGA FUNDS | 0.00% | 1,890 | - | - | Feb 29, 2024 |
| DELAWARE VIP TRUST | 0.00% | 14,000 | - | - | Dec 29, 2023 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 36,300 | - | - | Dec 31, 2023 |
| Calvert Variable Products, Inc. | 0.00% | 9,819 | - | - | Dec 31, 2023 |
| Lattice Strategies Trust | 0.00% | 6,832 | - | - | Dec 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED FUND IV | 0.00% | 798,000 | - | - | Jan 31, 2024 |
| MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC | 0.00% | 1,878 | 1,878 | - | Sep 30, 2020 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 98,976 | 36,072 | 57.34% | Dec 31, 2023 |
| VALIC Co II | 0.00% | 99,074 | 3,102 | 3.23% | Feb 28, 2021 |
| SCHWAB STRATEGIC TRUST | 0.00% | 516,635 | 52,905 | 11.41% | Feb 29, 2024 |
| SHELTON FUNDS | 0.00% | 4,320 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 530,290 | -336,298 | -38.81% | Feb 29, 2024 |
| PRAXIS MUTUAL FUNDS | 0.00% | 28,080 | - | - | Dec 31, 2023 |
| Pacer Funds Trust | 0.00% | 117,817 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 72,373 | - | -0.00% | Dec 31, 2023 |
| JPMORGAN TRUST II | 0.00% | 2,391,579 | - | - | Feb 29, 2024 |
| BMO FUNDS, INC. | 0.00% | 90,505 | -9,416 | -9.42% | Nov 30, 2021 |
Coherus BioSciences's largest mutual fund holder by % of total assets is "SCHRODER GLOBAL SERIES TRUST", owning 23.93K shares, compromising 11.73% of its total assets.
Coherus BioSciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 142 | -10.69% |
| 31 Dec, 23 | 159 | -6.47% |
| 30 Sep, 23 | 170 | 3.66% |
| 30 Jun, 23 | 164 | -1.20% |
| 31 Mar, 23 | 166 | -1.19% |
| 31 Dec, 22 | 168 | -1.18% |
| 30 Sep, 22 | 170 | -2.86% |
| 30 Jun, 22 | 175 | -1.13% |
| 31 Mar, 22 | 177 | -7.81% |
| 31 Dec, 21 | 192 | 1.59% |
| 30 Sep, 21 | 189 | -2.07% |
| 30 Jun, 21 | 193 | -7.21% |
| 31 Mar, 21 | 208 | 7.77% |
| 31 Dec, 20 | 193 | -3.98% |
| 30 Sep, 20 | 201 | 6.35% |
| 30 Jun, 20 | 189 | -1.05% |
| 31 Mar, 20 | 191 | - |
| 31 Dec, 19 | 191 | 13.02% |
| 30 Sep, 19 | 169 | 14.97% |
| 30 Jun, 19 | 147 | 23.53% |
| 31 Mar, 19 | 119 | 6.25% |
| 31 Dec, 18 | 112 | -1.75% |
| 30 Sep, 18 | 114 | -9.52% |
| 30 Jun, 18 | 126 | 17.76% |
| 31 Mar, 18 | 107 | 5.94% |
| 31 Dec, 17 | 101 | 1.00% |
| 30 Sep, 17 | 100 | -16.67% |
| 30 Jun, 17 | 120 | 2.56% |
| 31 Mar, 17 | 117 | -7.14% |
| 31 Dec, 16 | 126 | 3.28% |
| 30 Sep, 16 | 122 | 37.08% |
| 30 Jun, 16 | 89 | 17.11% |
| 31 Mar, 16 | 76 | -2.56% |
| 31 Dec, 15 | 78 | - |
| 30 Sep, 15 | 78 | 2.63% |
| 30 Jun, 15 | 76 | 52.00% |
| 31 Mar, 15 | 50 | 35.14% |
| 31 Dec, 14 | 37 | - |
As of 31 Mar 24, 142 institutions are holding Coherus BioSciences's shares, representing a decrease of -10.69% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 81,610,177 | 1.34% |
| 31 Dec, 23 | 80,529,854 | -12.76% |
| 30 Sep, 23 | 92,307,388 | 7.26% |
| 30 Jun, 23 | 86,059,069 | 10.38% |
| 31 Mar, 23 | 77,964,422 | -0.50% |
| 31 Dec, 22 | 78,358,457 | 1.46% |
| 30 Sep, 22 | 77,234,577 | -2.01% |
| 30 Jun, 22 | 78,820,138 | 4.46% |
| 31 Mar, 22 | 75,454,998 | -0.47% |
| 31 Dec, 21 | 75,809,753 | 0.62% |
| 30 Sep, 21 | 75,341,913 | -1.94% |
| 30 Jun, 21 | 76,833,318 | -3.18% |
| 31 Mar, 21 | 79,357,393 | -8.44% |
| 31 Dec, 20 | 86,676,822 | 1.34% |
| 30 Sep, 20 | 85,530,366 | -1.07% |
| 30 Jun, 20 | 86,459,468 | 16.05% |
| 31 Mar, 20 | 74,498,884 | 2.76% |
| 31 Dec, 19 | 72,495,341 | 4.83% |
| 30 Sep, 19 | 69,157,756 | 3.97% |
| 30 Jun, 19 | 66,519,206 | -3.32% |
| 31 Mar, 19 | 68,803,022 | 4.80% |
| 31 Dec, 18 | 65,652,291 | 3.22% |
| 30 Sep, 18 | 63,605,773 | 2.67% |
| 30 Jun, 18 | 61,953,517 | 12.07% |
| 31 Mar, 18 | 55,279,692 | 11.70% |
| 31 Dec, 17 | 49,490,380 | 5.46% |
| 30 Sep, 17 | 46,928,926 | 17.06% |
| 30 Jun, 17 | 40,089,238 | 6.73% |
| 31 Mar, 17 | 37,560,383 | 25.63% |
| 31 Dec, 16 | 29,898,450 | 6.29% |
| 30 Sep, 16 | 28,128,289 | 11.08% |
| 30 Jun, 16 | 25,322,017 | 38.87% |
| 31 Mar, 16 | 18,234,723 | 9.04% |
| 31 Dec, 15 | 16,722,254 | -26.78% |
| 30 Sep, 15 | 22,838,452 | 51.64% |
| 30 Jun, 15 | 15,061,051 | 107.21% |
| 31 Mar, 15 | 7,268,447 | -26.04% |
| 31 Dec, 14 | 9,827,386 | - |
Coherus BioSciences (CHRS) has 81.61M shares outstanding as of 31 Mar 24, up 1.34% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 86.67% | 1.28% |
| 31 Dec, 23 | 82.39% | 0.74% |
| 30 Sep, 23 | 105.77% | 0.90% |
| 30 Jun, 23 | 108.57% | 1.12% |
| 31 Mar, 23 | 98.35% | 0.97% |
| 31 Dec, 22 | 100.94% | 1.02% |
| 30 Sep, 22 | 99.34% | 0.96% |
| 30 Jun, 22 | 101.63% | 1.07% |
| 31 Mar, 22 | 97.67% | 0.97% |
| 31 Dec, 21 | 100.48% | 1.11% |
| 30 Sep, 21 | 95.35% | 0.92% |
| 30 Jun, 21 | 101.69% | 0.86% |
| 31 Mar, 21 | 108.96% | 0.74% |
| 31 Dec, 20 | 121.38% | 0.85% |
| 30 Sep, 20 | 119.37% | 0.81% |
| 30 Jun, 20 | 121.60% | 1.09% |
| 31 Mar, 20 | 105.43% | 0.99% |
| 31 Dec, 19 | 103.26% | 1.05% |
| 30 Sep, 19 | 98.97% | 1.08% |
| 30 Jun, 19 | 95.74% | 0.97% |
| 31 Mar, 19 | 99.51% | 1.07% |
| 31 Dec, 18 | 96.42% | 1.10% |
| 30 Sep, 18 | 93.75% | 1.00% |
| 30 Jun, 18 | 96.86% | 1.15% |
| 31 Mar, 18 | 91.95% | 1.06% |
| 31 Dec, 17 | 93.14% | 1.24% |
| 30 Sep, 17 | 86.79% | 1.42% |
| 30 Jun, 17 | 78.16% | 1.31% |
| 31 Mar, 17 | 77.11% | 1.52% |
| 31 Dec, 16 | 71.34% | 1.70% |
| 30 Sep, 16 | 64.71% | 1.67% |
| 30 Jun, 16 | 62.22% | 2.86% |
| 31 Mar, 16 | 46.64% | 2.53% |
| 31 Dec, 15 | 42.95% | 1.22% |
| 30 Sep, 15 | 59.43% | 3.72% |
| 30 Jun, 15 | 39.98% | 8.43% |
| 31 Mar, 15 | 21.78% | 0.89% |
| 31 Dec, 14 | 49.53% | - |
As of 31 Mar 24, Coherus BioSciences is held by 86.67% institutional shareholders, representing a 1.28% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 59 | -26.25% |
| 31 Dec, 23 | 80 | -22.33% |
| 30 Sep, 23 | 103 | 6.19% |
| 30 Jun, 23 | 97 | 46.97% |
| 31 Mar, 23 | 66 | -19.51% |
| 31 Dec, 22 | 82 | -6.82% |
| 30 Sep, 22 | 88 | -7.37% |
| 30 Jun, 22 | 95 | 21.79% |
| 31 Mar, 22 | 78 | -6.02% |
| 31 Dec, 21 | 83 | 12.16% |
| 30 Sep, 21 | 74 | -27.45% |
| 30 Jun, 21 | 102 | -7.27% |
| 31 Mar, 21 | 110 | 22.22% |
| 31 Dec, 20 | 90 | -20.35% |
| 30 Sep, 20 | 113 | -2.59% |
| 30 Jun, 20 | 116 | 19.59% |
| 31 Mar, 20 | 97 | -17.80% |
| 31 Dec, 19 | 118 | 22.92% |
| 30 Sep, 19 | 96 | 11.63% |
| 30 Jun, 19 | 86 | 30.30% |
| 31 Mar, 19 | 66 | 8.20% |
| 31 Dec, 18 | 61 | 7.02% |
| 30 Sep, 18 | 57 | -21.92% |
| 30 Jun, 18 | 73 | 23.73% |
| 31 Mar, 18 | 59 | 15.69% |
| 31 Dec, 17 | 51 | 2.00% |
| 30 Sep, 17 | 50 | -30.56% |
| 30 Jun, 17 | 72 | -2.70% |
| 31 Mar, 17 | 74 | 7.25% |
| 31 Dec, 16 | 69 | -11.54% |
| 30 Sep, 16 | 78 | 18.18% |
| 30 Jun, 16 | 66 | 43.48% |
| 31 Mar, 16 | 46 | - |
| 31 Dec, 15 | 46 | - |
| 30 Sep, 15 | 46 | -26.98% |
| 30 Jun, 15 | 63 | 70.27% |
| 31 Mar, 15 | 37 | - |
| 31 Dec, 14 | 37 | - |
59 institutional shareholders have increased their position in CHRS stock as of 31 Mar 24 compared to 80 in the previous quarter (a -26.25% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 54 | -1.82% |
| 31 Dec, 23 | 55 | 19.57% |
| 30 Sep, 23 | 46 | 9.52% |
| 30 Jun, 23 | 42 | -35.38% |
| 31 Mar, 23 | 65 | 18.18% |
| 31 Dec, 22 | 55 | -5.17% |
| 30 Sep, 22 | 58 | 9.43% |
| 30 Jun, 22 | 53 | -22.06% |
| 31 Mar, 22 | 68 | -8.11% |
| 31 Dec, 21 | 74 | -2.63% |
| 30 Sep, 21 | 76 | 33.33% |
| 30 Jun, 21 | 57 | -13.64% |
| 31 Mar, 21 | 66 | -4.35% |
| 31 Dec, 20 | 69 | 11.29% |
| 30 Sep, 20 | 62 | 14.81% |
| 30 Jun, 20 | 54 | -18.18% |
| 31 Mar, 20 | 66 | 46.67% |
| 31 Dec, 19 | 45 | 4.65% |
| 30 Sep, 19 | 43 | 7.50% |
| 30 Jun, 19 | 40 | 29.03% |
| 31 Mar, 19 | 31 | -3.13% |
| 31 Dec, 18 | 32 | -17.95% |
| 30 Sep, 18 | 39 | 39.29% |
| 30 Jun, 18 | 28 | -6.67% |
| 31 Mar, 18 | 30 | 7.14% |
| 31 Dec, 17 | 28 | 12.00% |
| 30 Sep, 17 | 25 | 8.70% |
| 30 Jun, 17 | 23 | -8.00% |
| 31 Mar, 17 | 25 | -32.43% |
| 31 Dec, 16 | 37 | 68.18% |
| 30 Sep, 16 | 22 | 100.00% |
| 30 Jun, 16 | 11 | -35.29% |
| 31 Mar, 16 | 17 | -26.09% |
| 31 Dec, 15 | 23 | 9.52% |
| 30 Sep, 15 | 21 | 200.00% |
| 30 Jun, 15 | 7 | -30.00% |
| 31 Mar, 15 | 10 | - |
| 31 Dec, 14 | - | - |
54 institutional shareholders have reduced their position in CHRS stock as of 31 Mar 24 compared to 55 in the previous quarter (a -1.82% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 142 | -10.69% | 81,610,177 | 1.34% | 86.67% | 1.28% | 59 | -26.25% | 54 | -1.82% |
| 31 Dec, 23 | 159 | -6.47% | 80,529,854 | -12.76% | 82.39% | 0.74% | 80 | -22.33% | 55 | 19.57% |
| 30 Sep, 23 | 170 | 3.66% | 92,307,388 | 7.26% | 105.77% | 0.90% | 103 | 6.19% | 46 | 9.52% |
| 30 Jun, 23 | 164 | -1.20% | 86,059,069 | 10.38% | 108.57% | 1.12% | 97 | 46.97% | 42 | -35.38% |
| 31 Mar, 23 | 166 | -1.19% | 77,964,422 | -0.50% | 98.35% | 0.97% | 66 | -19.51% | 65 | 18.18% |
| 31 Dec, 22 | 168 | -1.18% | 78,358,457 | 1.46% | 100.94% | 1.02% | 82 | -6.82% | 55 | -5.17% |
| 30 Sep, 22 | 170 | -2.86% | 77,234,577 | -2.01% | 99.34% | 0.96% | 88 | -7.37% | 58 | 9.43% |
| 30 Jun, 22 | 175 | -1.13% | 78,820,138 | 4.46% | 101.63% | 1.07% | 95 | 21.79% | 53 | -22.06% |
| 31 Mar, 22 | 177 | -7.81% | 75,454,998 | -0.47% | 97.67% | 0.97% | 78 | -6.02% | 68 | -8.11% |
| 31 Dec, 21 | 192 | 1.59% | 75,809,753 | 0.62% | 100.48% | 1.11% | 83 | 12.16% | 74 | -2.63% |
| 30 Sep, 21 | 189 | -2.07% | 75,341,913 | -1.94% | 95.35% | 0.92% | 74 | -27.45% | 76 | 33.33% |
| 30 Jun, 21 | 193 | -7.21% | 76,833,318 | -3.18% | 101.69% | 0.86% | 102 | -7.27% | 57 | -13.64% |
| 31 Mar, 21 | 208 | 7.77% | 79,357,393 | -8.44% | 108.96% | 0.74% | 110 | 22.22% | 66 | -4.35% |
| 31 Dec, 20 | 193 | -3.98% | 86,676,822 | 1.34% | 121.38% | 0.85% | 90 | -20.35% | 69 | 11.29% |
| 30 Sep, 20 | 201 | 6.35% | 85,530,366 | -1.07% | 119.37% | 0.81% | 113 | -2.59% | 62 | 14.81% |
| 30 Jun, 20 | 189 | -1.05% | 86,459,468 | 16.05% | 121.60% | 1.09% | 116 | 19.59% | 54 | -18.18% |
| 31 Mar, 20 | 191 | - | 74,498,884 | 2.76% | 105.43% | 0.99% | 97 | -17.80% | 66 | 46.67% |
| 31 Dec, 19 | 191 | 13.02% | 72,495,341 | 4.83% | 103.26% | 1.05% | 118 | 22.92% | 45 | 4.65% |
| 30 Sep, 19 | 169 | 14.97% | 69,157,756 | 3.97% | 98.97% | 1.08% | 96 | 11.63% | 43 | 7.50% |
| 30 Jun, 19 | 147 | 23.53% | 66,519,206 | -3.32% | 95.74% | 0.97% | 86 | 30.30% | 40 | 29.03% |
| 31 Mar, 19 | 119 | 6.25% | 68,803,022 | 4.80% | 99.51% | 1.07% | 66 | 8.20% | 31 | -3.13% |
| 31 Dec, 18 | 112 | -1.75% | 65,652,291 | 3.22% | 96.42% | 1.10% | 61 | 7.02% | 32 | -17.95% |
| 30 Sep, 18 | 114 | -9.52% | 63,605,773 | 2.67% | 93.75% | 1.00% | 57 | -21.92% | 39 | 39.29% |
| 30 Jun, 18 | 126 | 17.76% | 61,953,517 | 12.07% | 96.86% | 1.15% | 73 | 23.73% | 28 | -6.67% |
| 31 Mar, 18 | 107 | 5.94% | 55,279,692 | 11.70% | 91.95% | 1.06% | 59 | 15.69% | 30 | 7.14% |
| 31 Dec, 17 | 101 | 1.00% | 49,490,380 | 5.46% | 93.14% | 1.24% | 51 | 2.00% | 28 | 12.00% |
| 30 Sep, 17 | 100 | -16.67% | 46,928,926 | 17.06% | 86.79% | 1.42% | 50 | -30.56% | 25 | 8.70% |
| 30 Jun, 17 | 120 | 2.56% | 40,089,238 | 6.73% | 78.16% | 1.31% | 72 | -2.70% | 23 | -8.00% |
| 31 Mar, 17 | 117 | -7.14% | 37,560,383 | 25.63% | 77.11% | 1.52% | 74 | 7.25% | 25 | -32.43% |
| 31 Dec, 16 | 126 | 3.28% | 29,898,450 | 6.29% | 71.34% | 1.70% | 69 | -11.54% | 37 | 68.18% |
| 30 Sep, 16 | 122 | 37.08% | 28,128,289 | 11.08% | 64.71% | 1.67% | 78 | 18.18% | 22 | 100.00% |
| 30 Jun, 16 | 89 | 17.11% | 25,322,017 | 38.87% | 62.22% | 2.86% | 66 | 43.48% | 11 | -35.29% |
| 31 Mar, 16 | 76 | -2.56% | 18,234,723 | 9.04% | 46.64% | 2.53% | 46 | - | 17 | -26.09% |
| 31 Dec, 15 | 78 | - | 16,722,254 | -26.78% | 42.95% | 1.22% | 46 | - | 23 | 9.52% |
| 30 Sep, 15 | 78 | 2.63% | 22,838,452 | 51.64% | 59.43% | 3.72% | 46 | -26.98% | 21 | 200.00% |
| 30 Jun, 15 | 76 | 52.00% | 15,061,051 | 107.21% | 39.98% | 8.43% | 63 | 70.27% | 7 | -30.00% |
| 31 Mar, 15 | 50 | 35.14% | 7,268,447 | -26.04% | 21.78% | 0.89% | 37 | - | 10 | - |
| 31 Dec, 14 | 37 | - | 9,827,386 | - | 49.53% | - | 37 | - | - | - |
Coherus BioSciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Coherus BioSciences's stock was made by Wahlstrom Mats on Feb 15 2024, selling 99,988 shares at - per share (valued at -).
Coherus BioSciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 7 | 8 | 87.50% |
| Q4 2023 | 2 | 4 | 50.00% |
| Q3 2023 | 1 | - | - |
| Q2 2023 | 10 | 2 | 500.00% |
| Q1 2023 | 9 | 12 | 75.00% |
| Q4 2022 | - | 1 | - |
| Q3 2022 | 1 | - | - |
| Q2 2022 | 2 | 2 | 100.00% |
| Q1 2022 | 18 | 2 | 900.00% |
| Q4 2021 | - | 2 | - |
| Q3 2021 | 2 | 3 | 66.67% |
| Q2 2021 | 9 | 3 | 300.00% |
| Q1 2021 | 25 | 22 | 113.64% |
| Q4 2020 | 14 | 27 | 51.85% |
| Q3 2020 | 10 | 12 | 83.33% |
| Q2 2020 | 6 | 13 | 46.15% |
| Q1 2020 | 27 | 23 | 117.39% |
| Q4 2019 | 5 | 15 | 33.33% |
| Q3 2019 | 5 | 14 | 35.71% |
| Q2 2019 | 2 | 10 | 20.00% |
7 total buy trades, and 8 total sell trades (buy/sell ratio of 0.88%) were made by Coherus BioSciences's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | - | - | - |
| Q4 2023 | - | 1 | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 1 | - |
| Q3 2021 | - | 3 | - |
| Q2 2021 | 1 | 1 | 100.00% |
| Q1 2021 | - | 8 | - |
| Q4 2020 | - | 13 | - |
| Q3 2020 | - | 3 | - |
| Q2 2020 | - | 7 | - |
| Q1 2020 | - | 10 | - |
| Q4 2019 | - | 9 | - |
| Q3 2019 | - | 9 | - |
| Q2 2019 | - | 8 | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Coherus BioSciences's stocks.
Coherus BioSciences Peer Ownership
CHRS Ownership FAQ
Who Owns Coherus BioSciences?
Coherus BioSciences is owned by institutional shareholders (86.67%), insiders (1.39%), and public (11.94%). The largest institutional shareholder of Coherus BioSciences is BLACKROCK INC. (11.93% of total shares) and the top mutual fund owner is SCHRODER GLOBAL SERIES TRUST (11.73% of total shares).
Who are the major institutional shareholders of Coherus BioSciences?
Coherus BioSciences's major institutional shareholders are BLACKROCK INC., RUBRIC CAPITAL MANAGEMENT LP, VANGUARD GROUP INC, TEMASEK HOLDINGS (PRIVATE) LTD, and KOHLBERG KRAVIS ROBERTS & CO. L.P.. The top five shareholders own together 44.74% of the company's share outstanding.
How many Coherus BioSciences shareholders are there?
As of Mar 2024, there are 142 institutional shareholders of Coherus BioSciences.
What percentage of Coherus BioSciences is owned by BLACKROCK INC?
BLACKROCK INC owns 11.23M shares of Coherus BioSciences, representing 11.93% of the company's total shares outstanding, valued at $26.84M (as of Mar 2024).
What percentage of Coherus BioSciences is owned by RUBRIC CAPITAL MANAGEMENT LP?
As of Mar 2024, RUBRIC CAPITAL MANAGEMENT LP holds 10.4M shares of Coherus BioSciences (CHRS), compromising 11.04% of the company, valued at $24.86M.
What percentage of Coherus BioSciences is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Coherus BioSciences. The company owns 10.08M of the company's shares outstanding (worth $24.09M).